9877 — Jenscare Scientific Co Share News
0.000.00%
- HK$2.99bn
- HK$2.42bn
- CNY90.59m
Brief: Jenscare Scientific Announces Enrollment In Total Product Life Cycle Advisory Program Of U.S. FDA
Brief: Jenscare Scientific Says HY Loss Attributable Rmb175.8 Million
Brief: Jenscare Scientific Says FDA Accepted Early Feasibility Study Of Lux-Valve Plus
Brief: Jenscare Scientific Proposes To Apply For Allotment And Issue Of A Shares
Brief: Jenscare Scientific Posts FY Loss Attributable RMB439.3 Million